Aim: The aim of this study is to assess the benefits of a nurse-led home injection service for somatuline autogel-treated patients with acromegaly, including the adherence to treatment and disease control.
Methods: Historical prospective data of all patients with acromegaly initiating somatuline autogel between November 14, 2000, and March 9, 2020, who voluntarily enrolled in the nurse-led home injection service between January 1, 2018 and June 30, 2020. Adherence to treatment was calculated as the number of administered injections divided by the number of expected injections during the follow-up period. Excellent adherence to treatment was defined when >90% of scheduled injections were administered, while low adherence was defined when patients received <80% of expected injections. The primary outcome was the adherence to treatment.
Results: The cohort included 88 patients (mean age ± SD, 59.8 ± 14.9 years, 53% men). Average adherence to treatment was 93 ± 8% (range 62-100%). Excellent adherence was documented in 65 participants (74%), of which 29 patients (33%) received all scheduled injections. Low adherence to treatment was recorded in seven patients (8%). Average adherence was high independent of gender, age, prior surgery, or radiation therapy, or whether somatuline autogel was used as monotherapy or in combination regimens. However, excellent adherence decreased with increased somatuline dose and with dosing interval of 21 days. Average adherence was slightly higher in patients with biochemically controlled acromegaly.
Conclusions: A nurse-led home injection service for somatuline autogel injections is associated with high adherence to treatment. Establishing such a program globally may lead to better adherence to treatment and improved disease control.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12020-020-02529-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Original Research: Exploring the Use of Passive vs. Active Insulin Safety Pen Needle Devices in a Pediatric Population: A Feasibility Study.
Am J Nurs
January 2025
Brenna Frankish is the clinical learning programs coordinator at Children's Healthcare of Atlanta, where Kristina Amplo is the campus education coordinator and Christina Calamaro is the director of nursing research and evidence-based practice for nursing and allied health. Rachael Townsend is the pediatric program manager at Wellstar Health System in Marietta, GA. Tonya Miller-Roberts is a clinical psychologist at the Atlanta VA Medical Center in Decatur, GA. Akane Fujimoto Wakabayashi is a graduate research assistant at the Georgia Institute of Technology in Atlanta. This study was supported through funding from Owen Mumford, Ltd, which also supplied the active safety pen needle devices used. Contact author: Brenna Frankish, . The authors have disclosed no potential conflicts of interest, financial or otherwise.
Background: Insulin pens are the mainstay of insulin delivery in the pediatric population, especially among patients unable to use an insulin pump. Safety pen needle (SPN) devices have been embraced by both nurses and patients because they limit the risks of needlestick injury and exposure to blood-borne pathogens. With the commonly used traditional passive SPN device, however, it can be difficult to observe that the dose has been accurately or fully administered.
View Article and Find Full Text PDFExternalized nurse-led model for hepatitis C virus microelimination and impact of drug use profile.
Gastroenterol Hepatol
November 2024
Liver Unit, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address:
Background And Objective: Direct-acting antivirals have greatly simplified the treatment of hepatitis C virus (HCV), yet circuits that bring diagnosis and treatment closer to people who inject drugs (PWID) are needed to achieve the elimination targets of the WHO. With this purpose we have established an externalized nurse-driven circuit among former and active PWID in an addiction centre (AC) and a harm reduction centre (HRC).
Methods And Settings: The nursing staff offered HCV screening, diagnosis and treatment to the AC and HRC users, administered medication after the hepatologist's remote prescription to those with an active infection who accepted being treated, and implemented educational and harm reduction interventions.
Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review.
Pediatr Dermatol
November 2024
Department of Dermatology, University of Washington, Seattle, Washington, USA.
Introduction: Adherence to pediatric atopic dermatitis (AD) treatment regimens can be complex and a major challenge to optimizing treatment outcome. We aimed to review factors associated with nonadherence in pediatric AD and propose interventions to improve adherence.
Methods: PubMed and EMBASE databases were systematically searched for articles from 2000 to February 2023 related to AD and adherence, with an additional update in December 2023.
Outcomes of a patient support programme for subcutaneous immunoglobulin therapy in patients with primary or secondary immunodeficiencies or chronic inflammatory demyelinating polyneuropathy.
Intern Med J
November 2024
CSL Behring, Melbourne, Victoria, Australia.
Background: Subcutaneous immunoglobulin (SCIg) therapy is important in the treatment of primary (PID) and secondary immunodeficiencies (SID) and chronic inflammatory demyelinating polyneuropathy (CIDP). Patient support programmes (PSPs) help patients self-administer medication regimens and play a more active role in the self-management of their medical conditions.
Aim: To describe the effectiveness of the CSL Behring CARES PSP in optimising the quality use of SCIg in a hospital-free environment.
Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia.
Clin Infect Dis
September 2024
Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
Article Synopsis
- Prisons in Victoria, Australia, have implemented a statewide nurse-led model of care since 2015 to enhance hepatitis C testing and treatment among inmates, crucial for elimination efforts.
- From 2015 to 2021, 3,133 DAA treatment courses were prescribed to 2,768 inmates, with a significant increase in prescriptions over the years and a median age of treated individuals being 39.
- The program achieved a 93% success rate in sustained viral response (SVR12), demonstrating the effectiveness of decentralized, nurse-led initiatives in tackling hepatitis C in high-prevalence settings like prisons.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!